STATE OF NEW YORK
________________________________________________________________________
661
2015-2016 Regular Sessions
IN ASSEMBLY(Prefiled)
January 7, 2015
___________
Introduced by M. of A. BRAUNSTEIN -- read once and referred to the
Committee on Health
AN ACT to amend the public health law, in relation to prescribing an
opioid antagonist with a patient's first opioid analgesic prescription
in a given year
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Section 3302 of the public health law is amended by adding
2 two new subdivisions 44 and 45 to read as follows:
3 44. "Opioid analgesics" means the medicines buprenophine, butorphanol,
4 codeine, hydrocodone, hydromorphone, levorphanol, meperidine, methadone,
5 morphine, nalbuphine, oxycodone, oxymorphone, pentazocine, propoxyphene
6 as well as their brand names, isomers and combinations.
7 45. "Opioid antagonist" means an FDA-approved drug that, when adminis-
8 tered, negates or neutralizes in whole or in part the pharmacological
9 effects of an opioid in the body. The opioid antagonist is limited to
10 naloxone or other medications approved by the department for this
11 purpose.
12 § 2. Section 3309 of the public health law is amended by adding a new
13 subdivision 6 to read as follows:
14 6. Every initial opioid analgesic prescription per year shall be
15 accompanied with a prescription for an opioid antagonist.
16 § 3. This act shall take effect on the ninetieth day after it shall
17 have become a law; provided, however, that effective immediately, the
18 addition, amendment and/or repeal of any rule or regulation necessary
19 for the implementation of this act on its effective date is authorized
20 to be made and completed by the commissioner of health on or before such
21 effective date.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD02345-01-5
